Analytical Data
-
Gene name
PDCD6IP
- Application
-
Alternative Names
(PDCD6-interacting protein)(ALG-2-interacting protein 1)(ALG-2-interacting protein X)(Hp95)
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8WUM4
-
Expression Region
402-652aa
-
Molecular Weight
32.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PDCD6IP, also known as Programmed Cell Death 6 Interacting Protein, is a crucial regulator of cellular processes, particularly in apoptosis and endosomal pathways. Its role is highlighted in the context of various diseases, including neurodegenerative disorders and cancers, where its expression and function can be significantly altered. PDCD6IP is known to facilitate the sorting of proteins in multivesicular bodies and is involved in the formation of exosomes, small extracellular vesicles that play vital roles in cell communication and intercellular signaling. Research into PDCD6IP recombinant proteins aims to elucidate its mechanisms of action, interactions with other cellular pathways, and its potential as a therapeutic target. By generating and studying recombinant forms of PDCD6IP, scientists can better understand its structural properties and functional dynamics, which may provide insights into its role in disease pathology and offer new avenues for drug development. Additionally, the recombinant protein can be utilized in various assays to investigate its interactions with other molecular partners, enhancing our knowledge of its biological significance. Overall, PDCD6IP represents a promising area of research due to its complex involvement in critical cellular functions and implications for human health.
